Posard Matthew L.
SEC CIK 1543792 · EDGAR
BoughtSold
Most active insiders at HALO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Torley Helen | Pres AND CEO, Dir | — | $39.85M |
| 2 | Caudill Cortney | SVP, COO | — | $2.23M |
| 3 | Posard Matthew L. | Dir | — | $2.05M |
| 4 | Connaughton Bernadette | Dir | — | $989.9K |
| 5 | Krishnan Mahesh | Dir | — | $547.8K |
| 6 | LaBrosse Nicole | SVP, CFO | — | — |
| 7 | Snyder Mark Howard | SVP, CLO | — | — |
| 8 | Appelhans Dannielle | Dir | — | — |
| 9 | Lang James Paul | Dir | — | — |
| 10 | DUNCAN BARBARA GAYLE | Dir | — | — |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-09-17 17:19 | 2026-09-16 | HALO | HALOZYME THERAPEUTICS, INC. | Posard Matthew L. | Dir | S - Sale | $107.74 | -19.0K | 58.8K | -24% | -$2.05M |
| D | 2026-05-07 19:04 | 2026-05-05 | HALO | HALOZYME THERAPEUTICS, INC. | Posard Matthew L. | Dir | A - Grant | $0.00 | +3,796 | 77.8K | +5% | $0 |
| D | 2025-05-02 | 2025-05-01 | HALO | HALOZYME THERAPEUTICS, INC. | Posard Matthew L. | Dir | A - Grant | $0.00 | +4,165 | 74.0K | +6% | $0 |
| M | 2024-08-14 | 2024-08-12+ | HALO | HALOZYME THERAPEUTICS, INC. | Posard Matthew L. | Dir | S - Sale | $56.53 | -29.9K | 89.8K | -25% | -$1.69M |
| M | 2024-06-13 | 2024-06-11+ | HALO | HALOZYME THERAPEUTICS, INC. | Posard Matthew L. | Dir | S - Sale | $50.31 | -20.0K | 99.8K | -17% | -$1.01M |
| D | 2024-04-29 | 2024-04-25 | HALO | HALOZYME THERAPEUTICS, INC. | Posard Matthew L. | Dir | A - Grant | $0.00 | +6,501 | 119.8K | +6% | $0 |
| D | 2023-05-09 | 2023-05-05 | HALO | HALOZYME THERAPEUTICS, INC. | Posard Matthew L. | Dir | A - Grant | $0.00 | +8,065 | 113.3K | +8% | $0 |
| M | 2022-12-06 | 2022-12-02+ | HALO | HALOZYME THERAPEUTICS, INC. | Posard Matthew L. | Dir | S - Sale | $56.89 | -30.0K | 115.2K | -21% | -$1.71M |
| 2022-05-06 | 2022-05-05 | HALO | HALOZYME THERAPEUTICS, INC. | Posard Matthew L. | Dir | A - Grant | $0.00 | +6,206 | 135.2K | +5% | $0 | |
| M | 2021-12-01 | 2021-11-30+ | NAUT | Nautilus Biotechnology, Inc. | Posard Matthew L. | Dir | P - Purchase | $4.51 | +50.0K | 40.0K | New | +$225.5K |
Purchase Sale Sale after option exercise All abbreviations